Vera Therapeutics, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
Vera Therapeutics, Inc. is a Brisbane, California-based biotechnology company focused on developing therapies for serious immunological diseases. It operates as a clinical-stage organization seeking to improve patient outcomes in this field. The company’s lead program, MAU868, is a monoclonal antibody being studied to neutralize BK virus infections, which can have serious consequences for kidney transplant recipients. The company engages with the broader life sciences community through industry conferences and public disclosures. In May 2026, Vera Therapeutics announced that its management would present at the Bank of America Securities 2026 Health Care Conference in Las Vegas. This participation reflects ongoing efforts to communicate clinical progress within the immunology-focused biotechnology landscape.